A LncRNA MEG3 Variant Enhances Telomerase Activity by Increasing DNA Damage Repair Ability in Human Liver Cancer Stem Cells
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Gao X, Zou X, Guan C, Sha X, Liu S, Zhang X Cancer Gene Ther. 2024; 31(10):1585-1597.
PMID: 39210030 DOI: 10.1038/s41417-024-00826-z.
References
1.
Mohammed S, Shaker O, Mohamed M, Abdelhafez Mostafa M, Gaber S, Ali D
. The emerging role of lncRNA MEG3 and MEG3 rs7158663 in hepatocellular carcinoma. Eur Rev Med Pharmacol Sci. 2022; 26(1):11-21.
DOI: 10.26355/eurrev_202201_27742.
View
2.
Vaquero A, Scher M, Lee D, Sutton A, Cheng H, Alt F
. SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis. Genes Dev. 2006; 20(10):1256-61.
PMC: 1472900.
DOI: 10.1101/gad.1412706.
View
3.
Ali M, Shaker O, Alazrak M, AbdelHafez M, Khalefa A, Hemeda N
. Association analyses of a genetic variant in long non-coding RNA MEG3 with breast cancer susceptibility and serum MEG3 expression level in the Egyptian population. Cancer Biomark. 2020; 28(1):49-63.
DOI: 10.3233/CBM-191072.
View
4.
Ghafouri-Fard S, Taheri M
. Maternally expressed gene 3 (MEG3): A tumor suppressor long non coding RNA. Biomed Pharmacother. 2019; 118:109129.
DOI: 10.1016/j.biopha.2019.109129.
View
5.
Yang R, Liu Y, Cheng Y, Wang C, Song J, Lu G
. Effects and Molecular Mechanism of Single-Nucleotide Polymorphisms of MEG3 on Porcine Skeletal Muscle Development. Front Genet. 2021; 12:607910.
PMC: 7937967.
DOI: 10.3389/fgene.2021.607910.
View